ACTIVE

Allucent (Belgium)

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-1,5 M €-759,1 %over 1 year
Gross margin452,5 k €-83,4 %over 1 year
Equity1,1 M €-56,8 %over 1 year

Identity

Source · BCE/KBO

Allucent (Belgium) is a Private limited company incorporated in 2004. Its main activity is: Other professional, scientific and technical activities. Its registered office is in Scherpenheuvel-Zichem.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0869.582.927
Incorporation
19/10/2004
Legal form
Private limited company
Registered office
Dorp 14 box A
3272 Scherpenheuvel-Zichem · FlandreSee on map
Contributed capital
12 400,00 €
Latest accounts
31/12/2025
Joint committees (2)
  • 200
  • 218
Signals
Good liquidityHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 19 financial years

20252024202320222021
Income statement
Gross margin452,5 k €2,7 M €1,7 M €989,4 k €2,6 M €
EBITDA-1,9 M €610,8 k €407,9 k €-71,6 k €1,5 M €
Operating result-1,9 M €606,8 k €403 k €-73,9 k €1,5 M €
Net result-1,5 M €229,6 k €423 k €-165,2 k €1,1 M €
Balance sheet
Equity1,1 M €2,7 M €2,4 M €2 M €2,2 M €
Total assets11,8 M €11,4 M €11,1 M €7,5 M €4,9 M €
Cash19,5 k €275,8 k €685,5 k €258 k €2,4 M €
Debts8,6 M €8,3 M €7,7 M €4,3 M €2,5 M €
Other
Workforce––12,6 ETP12,7 ETP12,4 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 8 ended

Active mandates

Christopher BRENNAN

Bestuurder · since 16 décembre 2021

Active

Ended mandates

Christopher BRENNAN

Director · since 16 décembre 2021

Ended
Natalie GASSEN

Manager · since 13 mai 2019

Ended
Nathalie GASSEN

Director · since 13 mai 2019

Ended
Moshe Zev Munk

Manager · since 19 octobre 2004 · until 13 mai 2019

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date09/07/202613/07/202508/07/202416/08/202316/08/202229/06/2021
General meeting29/06/202619/06/202524/06/202430/06/202327/07/202228/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202529/06/202609/07/2026DutchPDF
Abridged model31/12/202419/06/202513/07/2025DutchPDF
Abridged model31/12/202324/06/202408/07/2024DutchPDF
Abridged model31/12/202230/06/202316/08/2023DutchPDF
Abridged model31/12/202127/07/202216/08/2022DutchPDF
Abridged model31/12/202028/06/202129/06/2021DutchPDF
Abridged model31/12/201929/06/202023/07/2020DutchPDF
Abridged model31/12/201824/06/201901/07/2019DutchPDF
Abridged model31/12/201730/06/201829/03/2019DutchPDF
Abridged model31/12/201630/06/201731/08/2017DutchPDF
Abridged model31/12/201527/06/201629/07/2016DutchPDF
Abridged model31/12/201429/06/201529/07/2015DutchPDF
Abridged model31/12/201330/06/201422/07/2014DutchPDF
Abridged model31/12/201224/06/201304/07/2013DutchPDF
Abridged model31/12/201125/06/201230/07/2012DutchPDF
Abridged model31/12/201027/06/201111/07/2011DutchPDF
Abridged model31/12/200928/06/201009/07/2010DutchPDF
Abridged model31/12/200829/06/200909/07/2009DutchPDF
Abridged model31/12/200730/06/200830/07/2008DutchPDF
Abridged model31/12/200630/07/200701/08/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 8 ended

Active mandates

Christopher BRENNAN

Bestuurder · since 16 décembre 2021

Active

Ended mandates

Christopher BRENNAN

Director · since 16 décembre 2021

Ended
Natalie GASSEN

Manager · since 13 mai 2019

Ended
Nathalie GASSEN

Director · since 13 mai 2019

Ended
Moshe Zev Munk

Manager · since 19 octobre 2004 · until 13 mai 2019

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other30/10/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - BENAMING
    PDF
  • Mandates29/08/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates07/02/2022
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates11/07/2019
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates01/02/2011
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates17/09/2010
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates08/07/2010
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates14/04/2010
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-1,5 M €↓
  2. 2024
    Annual accounts 2024229,6 k €↓
  3. 2024
    Name changeALLUCENT
  4. 2023
    Annual accounts 2023423 k €↑
  5. 2023
    Name changeAllucent (Belgium)
  6. 2022
    Annual accounts 2022-165,2 k €↓
  7. 2021
    Annual accounts 20211,1 M €↑
  8. 2020
    Annual accounts 2020684,3 k €↑
  9. 2019
    Annual accounts 201951,9 k €↑
  10. 2017
    Annual accounts 201730,1 k €↓
  11. 2016
    Annual accounts 201642,2 k €↓
  12. 2015
    Annual accounts 201555,9 k €↑
  13. 2014
    Annual accounts 201445,9 k €↑
  14. 2013
    Annual accounts 201338 k €↑
  15. 2012
    Annual accounts 201228,7 k €↓
  16. 2011
    Annual accounts 201153,7 k €↑
  17. 2010
    Annual accounts 201037,4 k €↑
  18. 2009
    Annual accounts 200932,7 k €↑
  19. 2008
    Annual accounts 2008-35,6 k €↓
  20. 2007
    Annual accounts 2007-17 k €↓
  21. 2006
    Annual accounts 200638,8 k €
  22. 2006
    Name changePHARM-OLAM INTERNATIONAL (BELGIUM)
  23. 19/10/2004
    IncorporationPrivate limited company